Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 127INDUSTRY 91NIH 31NETWORK 14OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Sarcoma 1Oesophagogastric Cancer 1Neoplasm Metastasis 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Lapatinib × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown
1,103 enrolled
Gastrointestinal

Oesophagogastric Cancer

NCT01730677 2014-03-12

LV

National Cancer Center, Korea

Phase 2 Unknown
150 enrolled
Breast

Breast Neoplasms

NCT01133912 2012-01-04

PGT

National Cancer Center, Korea

Phase 1 Completed
13 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡